Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2011
[A case of sigmoid colon cancer with temporary dysarthria associated with irinotecan]Susumu Sogabe, Satoshi Yuki, Hironobu Takano, et al.
Japanese Journal of Clinical Oncology|February 10, 2011
Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 studySusumu Sogabe, Yoshito Komatsu, Satoshi Yuki, et al.
Japanese Journal of Clinical Oncology|November 12, 2010
Randomized phase II study comparing dose escalated weekly paclitaxel vs. standard dose weekly paclitaxel for patients with previously treated advanced gastric cancerKohei Shitara, Isao Oze, Ayako Mizota, et al.
BMC Cancer|September 7, 2013
Simultaneous identification of 36 mutations in KRAS codons 61 and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kitHideaki Bando, Takayuki Yoshino, Eiji Shinozaki, et al.
BMC Cancer|September 11, 2015
Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancerYoshito Komatsu, Chikashi Ishioka, Ken Shimada, et al.
Oncology|June 11, 2011
Phase II study of combined treatment with irinotecan and S-1 (IRIS) in patients with inoperable or recurrent advanced colorectal cancer (HGCSG0302)Yoshito Komatsu, Satoshi Yuki, Susumu Sogabe, et al.
International Journal of Clinical Oncology|September 3, 2021
Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancerHiroyuki Okuyama, Yoshinori Kagawa, Toshiki Masuishi, et al.
Chemotherapy|February 1, 2013
Optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with modified FOLFOX6: a randomized pilot studyHiroshi Nakatsumi, Yoshito Komatsu, Satoshi Yuki, et al.
International Journal of Clinical Oncology|August 30, 2022
Usefulness of ultrasonography and elastography in diagnosing oxaliplatin-induced sinusoidal obstruction syndromeRika Saito, Yasuyuki Kawamoto, Mutsumi Nishida, et al.
The Oncologist|May 29, 2021
A Phase I Trial of Oxaliplatin, Irinotecan, and S-1 Combination Therapy (OX-IRIS) as Chemotherapy for Unresectable Pancreatic Cancer (HGCSG 1403)Yasuyuki Kawamoto, Hiroshi Nakatsumi, Kazuaki Harada, et al.
Pageof 12